Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1

Summary: AML is characterized by mutations in genes associated with growth regulation such as internal tandem duplications (ITD) in the receptor kinase FLT3. Inhibitors targeting FLT3 (FLT3i) are being used to treat patients with FLT3-ITD+ but most relapse and become resistant. To elucidate the resi...

詳細記述

書誌詳細

主要な著者:	Daniel J.L. Coleman, Peter Keane, Paulynn S. Chin, Luke Ames, Sophie Kellaway, Helen Blair, Naeem Khan, James Griffin, Elizabeth Holmes, Alexander Maytum, Sandeep Potluri, Lara Strate, Kinga Koscielniak, Manoj Raghavan, John Bushweller, Olaf Heidenreich, Terry Rabbitts, Peter N. Cockerill, Constanze Bonifer
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-04-01
シリーズ:	iScience
主題:	Pharmacy Molecular biology
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2589004224007983
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!